Live from the NIH registry
Studies recruiting near Mobile right now
Top 25 of 170 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
USA Health Strada Patient Care Center — Mobile, Alabama (4.5 mi)
· Sponsor: Children's Oncology Group
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm
Phase 2
Interventional 70 participants sought
University of South Alabama Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Southern Cancer Center Pc — Daphne, Alabama (13.7 mi)
· Sponsor: Bristol-Myers Squibb
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Cancer, Metastatic, Cancer
N/A
Observational 50,000 participants sought
Massive Bio SYNERGY-AI site — Mobile, Alabama (4.5 mi)
· Sponsor: Massive Bio, Inc.
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Heart Failure, Acute Heart Failure
Phase 3
Interventional 5,200 participants sought
Fairhope, AL Investigative Site 10004 — Fairhope, Alabama (16.6 mi)
· Sponsor: Colorado Prevention Center
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Southern Cancer Center — Daphne, Alabama (13.7 mi)
· Sponsor: SCRI Development Innovations, LLC
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 160 — Mobile, Alabama (4.5 mi)
· Sponsor: Merus B.V.
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Non-small Cell Lung Cancer
Phase 3
Interventional 1,000 participants sought
Local Institution - 0487 — Mobile, Alabama (4.5 mi)
· Sponsor: Bristol-Myers Squibb
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Phase 3
Interventional 670 participants sought
Infirmary Cancer Care — Mobile, Alabama (4.5 mi)
· Sponsor: Boehringer Ingelheim
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
Tricuspid Valve Disease
N/A
Interventional 78 participants sought
Springhill Memorial Hospital — Mobile, Alabama (4.5 mi)
· Sponsor: Corvivo Cardiovascular, Inc.
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Sickle Cell Disease
Phase 2, Phase 3
Interventional 389 participants sought
AMR Clinical — Mobile, Alabama (4.5 mi)
· Sponsor: Pfizer
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
Paroxysmal Atrial Fibrillation
N/A
Observational 250 participants sought
Mobile Cardiology Associates — Mobile, Alabama (4.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Mobile Heart Specialists PC — Mobile, Alabama (4.5 mi)
· Sponsor: Amgen
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
Alliance for Multispecialty Research - Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: pH-D Feminine Health LLC
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer
Phase 3
Interventional 186 participants sought
The University of South Alabama, Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: Genelux Corporation
MYLUNG Consortium Part 3: Observational Study
Carcinoma, Non-Small-Cell Lung
N/A
Observational 7,500 participants sought
Southern Cancer Center, PC — Daphne, Alabama (13.7 mi)
· Sponsor: US Oncology Research
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Mobile Heart USA Health Cardiology Clinic — Mobile, Alabama (4.5 mi)
· Sponsor: Novo Nordisk A/S
A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)
Lipoprotein(a)
Phase 2
Interventional 750 participants sought
AMR Clinical Mobile ( Site 0149) — Mobile, Alabama (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
USA Health Strada Patient Care Center — Mobile, Alabama (4.5 mi)
· Sponsor: PedAL BCU, LLC
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
Cardiovascular Disorder, Classic Hodgkin Lymphoma
N/A
Observational 190 participants sought
USA Health Strada Patient Care Center — Mobile, Alabama (4.5 mi)
· Sponsor: Children's Oncology Group
Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset
Infant, Extremely Premature, Obstetric Labor, Premature
N/A
Observational 5,000 participants sought
University of South Alabama — Mobile, Alabama (4.5 mi)
· Sponsor: The University of Texas Health Science Center, Houston
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Sickle Cell Disease
Phase 3
Interventional 510 participants sought
Univer South Alabama Ped/Onc — Mobile, Alabama (4.5 mi)
· Sponsor: Novo Nordisk A/S
Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia
Waldenstrom Macroglobulinemia
N/A
Observational 111 participants sought
South Alabama Medical Science Foundation Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: BeiGene
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
USA Mitchell Cancer Institute ( Site 0014) — Mobile, Alabama (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC